OP Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,835
Closed -$35.2K 827
2026
Q1
$35.2K Sell
1,835
-15,279
-89% -$332K ﹤0.01% 775
2025
Q4
$376K Hold
17,114
﹤0.01% 684
2025
Q3
$208K Hold
17,114
﹤0.01% 739
2025
Q2
$319K Sell
17,114
-5,886
-26% -$117K ﹤0.01% 711
2025
Q1
$441K Buy
+23,000
New +$673K 0.01% 694

Other funds holding TNDM

OP Asset Management's TNDM Position: Q2 2026 in Review

OP Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 1,835 shares — an estimated $35.2K sold.

OP Asset Management first reported a position in TNDM in Q1 2025 and held it in 5 quarters. The position peaked at $441K in Q1 2025. 57 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • OP Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 1,835 Tandem Diabetes Care shares in Q2 2026, an estimated $35.2K.
  • OP Asset Management first reported a position in Tandem Diabetes Care in Q1 2025 and held it in 5 quarters.
  • OP Asset Management's Tandem Diabetes Care position peaked at $441K in Q1 2025.
  • 57 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.